The IMF is pleased to bring you CITINGS - Novel Therapies, now published monthly, featuring the most up-to-date information on research advances and new therapies for the treatment for multiple myeloma. CITINGS - Novel Therapies provides physicians and other health care professionals with references and Internet links to the most current U.S. and international journal articles, abstracts, and white papers. Each issue presents articles related to new drugs, either as the focus of the study or as part of the discussion of myeloma treatment.
This special edition corresponds with the 2008 annual meeting of the American Society of Clinical Oncology (ASCO). In this CITINGS, we have highlighted selected thalidomide and Revlimid data presentations from the ASCO meeting. We also provide references to the latest published journal articles on both
thalidomide and Revlimid from the second quarter of this year.
This special edition corresponds with the 2008 annual meeting of the American Society of Clinical Oncology (ASCO). In this CITINGS, we have highlighted selected VELCADE data presentations from the ASCO meeting. We also provide references to the latest published journal articles on VELCADE from the second quarter of this year.
The IMF is pleased to bring you CITINGS - Novel Therapies, now published monthly, featuring the most up-to-date information on research advances and new therapies for the treatment for multiple myeloma. CITINGS - Novel Therapies provides physicians and other health care professionals with references and Internet links to the most current U.S. and international journal articles, abstracts, and white papers. Each issue presents articles related to new drugs, either as the focus of the study or as part of the discussion of myeloma treatment.
print
back to top